The present invention relates to peptide, protein, nucleic acid and cells to be used for immunotherapy method. In particular, the present invention relates to the immunotherapies of cancer. The invention additionally relates to relevant T cells to have found peptide epitopes, individually or can be with other tumor-associated peptides, such as the active pharmaceutical ingredient of stimulation anti tumor immune response vaccine composition, or for stimulating T cell and to be transferred to patient external. The molecule (MHC) or peptide itself for the peptide that major histocompatibility complex combines, can also be with the antibody of target, soluble T cell receptor and other binding molecules.
